These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7660281)
1. Effect of 4-aminopyridine in acute spinal cord injury. Haghighi SS; Pugh SL; Perez-Espejo MA; Oro JJ Surg Neurol; 1995 May; 43(5):443-7. PubMed ID: 7660281 [TBL] [Abstract][Full Text] [Related]
2. Effect of 4-aminopyridine and single-dose methylprednisolone on functional recovery after a chronic spinal cord injury. Haghighi SS; Clapper A; Johnson GC; Stevens A; Prapaisilp A Spinal Cord; 1998 Jan; 36(1):6-12. PubMed ID: 9471130 [TBL] [Abstract][Full Text] [Related]
3. Parallel Evaluation of Two Potassium Channel Blockers in Restoring Conduction in Mechanical Spinal Cord Injury in Rat. Page JC; Park J; Chen Z; Cao P; Shi R J Neurotrauma; 2018 May; 35(9):1057-1068. PubMed ID: 29228863 [TBL] [Abstract][Full Text] [Related]
4. Acrolein-mediated conduction loss is partially restored by K⁺ channel blockers. Yan R; Page JC; Shi R J Neurophysiol; 2016 Feb; 115(2):701-10. PubMed ID: 26581866 [TBL] [Abstract][Full Text] [Related]
5. 4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury. Hayes KC; Potter PJ; Wolfe DL; Hsieh JT; Delaney GA; Blight AR J Neurotrauma; 1994 Aug; 11(4):433-46. PubMed ID: 7837283 [TBL] [Abstract][Full Text] [Related]
6. 4-Aminopyridine derivatives enhance impulse conduction in guinea-pig spinal cord following traumatic injury. McBride JM; Smith DT; Byrn SR; Borgens RB; Shi R Neuroscience; 2007 Aug; 148(1):44-52. PubMed ID: 17629412 [TBL] [Abstract][Full Text] [Related]
7. Development of novel 4-aminopyridine derivatives as potential treatments for neurological injury and disease. Smith DT; Shi R; Borgens RB; McBride JM; Jackson K; Byrn SR Eur J Med Chem; 2005 Sep; 40(9):908-17. PubMed ID: 16055230 [TBL] [Abstract][Full Text] [Related]
8. The effects of taxol, methylprednisolone, and 4-aminopyridine in compressive spinal cord injury: a qualitative experimental study. Perez-Espejo MA; Haghighi SS; Adelstein EH; Madsen R Surg Neurol; 1996 Oct; 46(4):350-7. PubMed ID: 8876716 [TBL] [Abstract][Full Text] [Related]
9. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury. Cayli SR; Kocak A; Yilmaz U; Tekiner A; Erbil M; Ozturk C; Batcioglu K; Yologlu S Eur Spine J; 2004 Dec; 13(8):724-32. PubMed ID: 15232723 [TBL] [Abstract][Full Text] [Related]
10. Conduction block in acute and chronic spinal cord injury: different dose-response characteristics for reversal by 4-aminopyridine. Shi R; Kelly TM; Blight AR Exp Neurol; 1997 Dec; 148(2):495-501. PubMed ID: 9417828 [TBL] [Abstract][Full Text] [Related]
11. Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury. Hayes KC; Blight AR; Potter PJ; Allatt RD; Hsieh JT; Wolfe DL; Lam S; Hamilton JT Paraplegia; 1993 Apr; 31(4):216-24. PubMed ID: 8493036 [TBL] [Abstract][Full Text] [Related]
12. Delayed granulocyte colony-stimulating factor treatment promotes functional recovery in rats with severe contusive spinal cord injury. Lee JS; Yang CC; Kuo YM; Sze CI; Hsu JY; Huang YH; Tzeng SF; Tsai CL; Chen HH; Jou IM Spine (Phila Pa 1976); 2012 Jan; 37(1):10-7. PubMed ID: 22024901 [TBL] [Abstract][Full Text] [Related]
14. Novel potassium channel blocker, 4-AP-3-MeOH, inhibits fast potassium channels and restores axonal conduction in injured guinea pig spinal cord white matter. Sun W; Smith D; Fu Y; Cheng JX; Bryn S; Borgens R; Shi R J Neurophysiol; 2010 Jan; 103(1):469-78. PubMed ID: 19923250 [TBL] [Abstract][Full Text] [Related]
15. Assessment of axonal dysfunction in an in vitro model of acute compressive injury to adult rat spinal cord axons. Fehlings MG; Nashmi R Brain Res; 1995 Apr; 677(2):291-9. PubMed ID: 7552255 [TBL] [Abstract][Full Text] [Related]
16. Changes in pharmacological sensitivity of the spinal cord to potassium channel blockers following acute spinal cord injury. Fehlings MG; Nashmi R Brain Res; 1996 Oct; 736(1-2):135-45. PubMed ID: 8930318 [TBL] [Abstract][Full Text] [Related]
17. Clinically Relevant Levels of 4-Aminopyridine Strengthen Physiological Responses in Intact Motor Circuits in Rats, Especially After Pyramidal Tract Injury. Sindhurakar A; Mishra AM; Gupta D; Iaci JF; Parry TJ; Carmel JB Neurorehabil Neural Repair; 2017 Apr; 31(4):387-396. PubMed ID: 28107804 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic value of 21-aminosteroid U74389F in acute spinal cord injury. Haghighi SS; Hall ED; Geng XZ; Oro JJ; Johnson GC Neurol Res; 1993 Oct; 15(5):321-6. PubMed ID: 7905606 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels. Nashmi R; Fehlings MG Brain Res Brain Res Rev; 2001 Dec; 38(1-2):165-91. PubMed ID: 11750932 [TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of magnesium on lipid peroxidation and axonal function after experimental spinal cord injury. Süzer T; Coskun E; Islekel H; Tahta K Spinal Cord; 1999 Jul; 37(7):480-4. PubMed ID: 10438114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]